Regeneron Pharmaceuticals, Inc. (REGN)
USD 556.81
(-2.79%)
USD 556.81
(-2.79%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 13.11 Billion USD | 7.76% |
| 2022 | 12.17 Billion USD | -24.26% |
| 2021 | 16.07 Billion USD | 89.14% |
| 2020 | 8.49 Billion USD | 8.06% |
| 2019 | 7.86 Billion USD | 17.18% |
| 2018 | 6.71 Billion USD | 14.28% |
| 2017 | 5.87 Billion USD | 20.82% |
| 2016 | 4.86 Billion USD | 18.44% |
| 2015 | 4.1 Billion USD | 45.55% |
| 2014 | 2.81 Billion USD | 33.96% |
| 2013 | 2.1 Billion USD | 52.69% |
| 2012 | 1.37 Billion USD | 209.2% |
| 2011 | 445.82 Million USD | -2.89% |
| 2010 | 459.07 Million USD | 21.04% |
| 2009 | 379.26 Million USD | 59.05% |
| 2008 | 238.45 Million USD | 90.73% |
| 2007 | 125.02 Million USD | 97.05% |
| 2006 | 63.44 Million USD | -4.15% |
| 2005 | 66.19 Million USD | -61.96% |
| 2004 | 174.01 Million USD | 202.65% |
| 2003 | 57.49 Million USD | 161.49% |
| 2002 | 21.98 Million USD | 0.07% |
| 2001 | 21.97 Million USD | -62.93% |
| 2000 | 59.27 Million USD | 71.81% |
| 1999 | 34.5 Million USD | -9.69% |
| 1998 | 38.2 Million USD | 15.41% |
| 1997 | 33.1 Million USD | 37.34% |
| 1996 | 24.1 Million USD | -12.04% |
| 1995 | 27.4 Million USD | 18.1% |
| 1994 | 23.2 Million USD | 118.87% |
| 1993 | 10.6 Million USD | -7.83% |
| 1992 | 11.5 Million USD | 57.53% |
| 1991 | 7.3 Million USD | 46.0% |
| 1990 | 5 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 3.72 Billion USD | 4.89% |
| 2024 Q1 | 3.14 Billion USD | -8.42% |
| 2024 Q2 | 3.54 Billion USD | 12.79% |
| 2023 Q3 | 3.36 Billion USD | 6.48% |
| 2023 Q4 | 3.43 Billion USD | 2.13% |
| 2023 FY | 13.11 Billion USD | 7.76% |
| 2023 Q1 | 3.16 Billion USD | -7.39% |
| 2023 Q2 | 3.15 Billion USD | -0.13% |
| 2022 Q2 | 2.85 Billion USD | -3.64% |
| 2022 Q4 | 3.41 Billion USD | 16.29% |
| 2022 FY | 12.17 Billion USD | -24.26% |
| 2022 Q1 | 2.96 Billion USD | -40.12% |
| 2022 Q3 | 2.93 Billion USD | 2.76% |
| 2021 FY | 16.07 Billion USD | 89.14% |
| 2021 Q2 | 5.13 Billion USD | 103.21% |
| 2021 Q1 | 2.52 Billion USD | 4.37% |
| 2021 Q4 | 4.95 Billion USD | 43.41% |
| 2021 Q3 | 3.45 Billion USD | -32.81% |
| 2020 FY | 8.49 Billion USD | 8.06% |
| 2020 Q4 | 2.42 Billion USD | 5.62% |
| 2020 Q3 | 2.29 Billion USD | 17.52% |
| 2020 Q2 | 1.95 Billion USD | 6.77% |
| 2020 Q1 | 1.82 Billion USD | -15.73% |
| 2019 Q4 | 2.16 Billion USD | 5.91% |
| 2019 FY | 7.86 Billion USD | 17.18% |
| 2019 Q1 | 1.71 Billion USD | -11.2% |
| 2019 Q2 | 1.93 Billion USD | 12.96% |
| 2019 Q3 | 2.04 Billion USD | 5.93% |
| 2018 Q3 | 1.66 Billion USD | 3.45% |
| 2018 Q2 | 1.6 Billion USD | 6.39% |
| 2018 Q1 | 1.51 Billion USD | -4.48% |
| 2018 FY | 6.71 Billion USD | 14.28% |
| 2018 Q4 | 1.92 Billion USD | 15.89% |
| 2017 Q3 | 1.5 Billion USD | 2.08% |
| 2017 FY | 5.87 Billion USD | 20.82% |
| 2017 Q4 | 1.58 Billion USD | 5.45% |
| 2017 Q1 | 1.31 Billion USD | 7.51% |
| 2017 Q2 | 1.47 Billion USD | 11.46% |
| 2016 Q2 | 1.21 Billion USD | 0.98% |
| 2016 Q3 | 1.22 Billion USD | 0.62% |
| 2016 FY | 4.86 Billion USD | 18.44% |
| 2016 Q1 | 1.2 Billion USD | 9.36% |
| 2016 Q4 | 1.22 Billion USD | 0.55% |
| 2015 Q3 | 1.13 Billion USD | 13.9% |
| 2015 FY | 4.1 Billion USD | 45.55% |
| 2015 Q2 | 998.61 Million USD | 14.83% |
| 2015 Q4 | 1.09 Billion USD | -3.46% |
| 2015 Q1 | 869.61 Million USD | 8.39% |
| 2014 FY | 2.81 Billion USD | 33.96% |
| 2014 Q3 | 725.78 Million USD | 9.03% |
| 2014 Q2 | 665.7 Million USD | 6.39% |
| 2014 Q1 | 625.74 Million USD | 2.51% |
| 2014 Q4 | 802.32 Million USD | 10.55% |
| 2013 Q2 | 457.64 Million USD | 4.09% |
| 2013 Q3 | 597.02 Million USD | 30.46% |
| 2013 FY | 2.1 Billion USD | 52.69% |
| 2013 Q4 | 610.41 Million USD | 2.24% |
| 2013 Q1 | 439.66 Million USD | 6.04% |
| 2012 FY | 1.37 Billion USD | 209.2% |
| 2012 Q1 | 231.78 Million USD | 88.48% |
| 2012 Q2 | 304.39 Million USD | 31.33% |
| 2012 Q3 | 427.68 Million USD | 40.5% |
| 2012 Q4 | 414.6 Million USD | -3.06% |
| 2011 Q1 | 112.2 Million USD | -16.06% |
| 2011 FY | 445.82 Million USD | -2.89% |
| 2011 Q4 | 122.97 Million USD | 19.59% |
| 2011 Q3 | 102.83 Million USD | -4.62% |
| 2011 Q2 | 107.81 Million USD | -3.92% |
| 2010 Q3 | 105.97 Million USD | -8.55% |
| 2010 Q4 | 133.67 Million USD | 26.13% |
| 2010 FY | 459.07 Million USD | 21.04% |
| 2010 Q1 | 103.53 Million USD | 6.96% |
| 2010 Q2 | 115.88 Million USD | 11.93% |
| 2009 Q1 | 74.98 Million USD | 34.29% |
| 2009 Q2 | 90.03 Million USD | 20.07% |
| 2009 Q3 | 117.45 Million USD | 30.46% |
| 2009 Q4 | 96.8 Million USD | -17.59% |
| 2009 FY | 379.26 Million USD | 59.05% |
| 2008 Q3 | 65.58 Million USD | 8.13% |
| 2008 Q4 | 55.83 Million USD | -14.86% |
| 2008 FY | 238.45 Million USD | 90.73% |
| 2008 Q1 | 56.38 Million USD | -12.9% |
| 2008 Q2 | 60.65 Million USD | 7.57% |
| 2007 FY | 125.02 Million USD | 97.05% |
| 2007 Q4 | 64.73 Million USD | 190.13% |
| 2007 Q3 | 22.31 Million USD | 0.52% |
| 2007 Q2 | 22.19 Million USD | 40.58% |
| 2007 Q1 | 15.78 Million USD | 52.6% |
| 2006 Q3 | 15.62 Million USD | -18.87% |
| 2006 Q2 | 19.25 Million USD | 5.7% |
| 2006 Q1 | 18.21 Million USD | 4.56% |
| 2006 FY | 63.44 Million USD | -4.15% |
| 2006 Q4 | 10.34 Million USD | -33.78% |
| 2005 Q3 | 16.19 Million USD | -1.05% |
| 2005 Q1 | 16.2 Million USD | -65.58% |
| 2005 Q2 | 16.36 Million USD | 0.97% |
| 2005 FY | 66.19 Million USD | -61.96% |
| 2005 Q4 | 17.42 Million USD | 7.6% |
| 2004 Q3 | 36.51 Million USD | 28.51% |
| 2004 FY | 174.01 Million USD | 202.65% |
| 2004 Q1 | 61.99 Million USD | 191.42% |
| 2004 Q2 | 28.41 Million USD | -54.16% |
| 2004 Q4 | 47.09 Million USD | 28.95% |
| 2003 Q1 | 10.13 Million USD | 106.35% |
| 2003 FY | 57.49 Million USD | 161.49% |
| 2003 Q4 | 21.27 Million USD | 22.31% |
| 2003 Q3 | 17.39 Million USD | 65.13% |
| 2003 Q2 | 10.53 Million USD | 3.91% |
| 2002 Q1 | 4.94 Million USD | 12.27% |
| 2002 FY | 21.98 Million USD | 0.07% |
| 2002 Q2 | 5.56 Million USD | 12.71% |
| 2002 Q3 | 6.56 Million USD | 17.9% |
| 2002 Q4 | 4.91 Million USD | -25.19% |
| 2001 Q2 | 5.77 Million USD | -36.39% |
| 2001 FY | 21.97 Million USD | -62.93% |
| 2001 Q4 | 4.4 Million USD | -19.69% |
| 2001 Q3 | 5.48 Million USD | -5.17% |
| 2001 Q1 | 9.08 Million USD | -53.21% |
| 2000 FY | 59.27 Million USD | 71.81% |
| 2000 Q1 | 10.49 Million USD | -11.78% |
| 2000 Q2 | 14.45 Million USD | 37.7% |
| 2000 Q3 | 14.9 Million USD | 3.11% |
| 2000 Q4 | 19.41 Million USD | 30.26% |
| 1999 Q3 | 11.3 Million USD | 91.53% |
| 1999 Q4 | 11.9 Million USD | 5.31% |
| 1999 FY | 34.5 Million USD | -9.69% |
| 1999 Q1 | 5.5 Million USD | -25.68% |
| 1999 Q2 | 5.9 Million USD | 7.27% |
| 1998 Q3 | 10.8 Million USD | -20.0% |
| 1998 Q4 | 7.4 Million USD | -31.48% |
| 1998 FY | 38.2 Million USD | 15.41% |
| 1998 Q1 | 6.5 Million USD | -42.98% |
| 1998 Q2 | 13.5 Million USD | 107.69% |
| 1997 Q2 | 6.6 Million USD | 6.45% |
| 1997 FY | 33.1 Million USD | 37.34% |
| 1997 Q4 | 11.4 Million USD | 28.09% |
| 1997 Q3 | 8.9 Million USD | 34.85% |
| 1997 Q1 | 6.2 Million USD | -4.62% |
| 1996 FY | 24.1 Million USD | -12.04% |
| 1996 Q4 | 6.5 Million USD | 4.84% |
| 1996 Q3 | 6.2 Million USD | 0.0% |
| 1996 Q2 | 6.2 Million USD | 19.23% |
| 1996 Q1 | 5.2 Million USD | -10.34% |
| 1995 Q3 | 6.2 Million USD | -18.42% |
| 1995 Q4 | 5.8 Million USD | -6.45% |
| 1995 Q2 | 7.6 Million USD | 10.14% |
| 1995 Q1 | 6.9 Million USD | -10.39% |
| 1995 FY | 27.4 Million USD | 18.1% |
| 1994 Q4 | 7.7 Million USD | -13.48% |
| 1994 FY | 23.2 Million USD | 118.87% |
| 1994 Q1 | 3 Million USD | 3.45% |
| 1994 Q2 | 3.6 Million USD | 20.0% |
| 1994 Q3 | 8.9 Million USD | 147.22% |
| 1993 Q3 | 3.6 Million USD | 176.92% |
| 1993 Q2 | 1.3 Million USD | -38.1% |
| 1993 FY | 10.6 Million USD | -7.83% |
| 1993 Q1 | 2.1 Million USD | -8.7% |
| 1993 Q4 | 2.9 Million USD | -19.44% |
| 1992 Q1 | 3.5 Million USD | 75.0% |
| 1992 Q2 | 3.2 Million USD | -8.57% |
| 1992 Q3 | 2.4 Million USD | -25.0% |
| 1992 Q4 | 2.3 Million USD | -4.17% |
| 1992 FY | 11.5 Million USD | 57.53% |
| 1991 FY | 7.3 Million USD | 46.0% |
| 1991 Q4 | 2 Million USD | 5.26% |
| 1991 Q1 | 2 Million USD | 53.85% |
| 1991 Q3 | 1.9 Million USD | 11.76% |
| 1991 Q2 | 1.7 Million USD | -15.0% |
| 1990 Q3 | 1.3 Million USD | 8.33% |
| 1990 Q2 | 1.2 Million USD | 0.0% |
| 1990 Q1 | 1.2 Million USD | 0.0% |
| 1990 Q4 | 1.3 Million USD | 0.0% |
| 1990 FY | 5 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 194.62 Million USD | -6639.8% |
| Jaguar Health, Inc. | 9.76 Million USD | -134283.772% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -8686787.417% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | -617.457% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -9889.186% |
| ContextLogic Inc. | 287 Million USD | -4470.453% |
| MiMedx Group, Inc. | 321.47 Million USD | -3980.292% |
| MEI Pharma, Inc. | 65.29 Million USD | -19988.519% |
| AlloVir, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 983.7 Million USD | -1233.449% |
| Aptorum Group Limited | 431.37 Thousand USD | -3040667.03% |
| Ardelyx, Inc. | 124.45 Million USD | -10439.628% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -5348.813% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -210618.072% |
| Pharming Group N.V. | 245.31 Million USD | -5247.063% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -1923243.109% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -30540.505% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -11122.601% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -137109.205% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 26.97 Million USD | -48525.445% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | -7343.143% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -843992.664% |
| Acelyrin, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -512090.551% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -149298.633% |
| AbCellera Biologics Inc. | 38.02 Million USD | -34396.252% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -262343900.0% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -950421.739% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -10067.347% |
| Chimerix, Inc. | 324 Thousand USD | -4048418.519% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -1232719.549% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.66 Billion USD | -688.575% |
| Fortress Biotech, Inc. | 84.51 Million USD | -15420.926% |
| Fortress Biotech, Inc. | 84.51 Million USD | -15420.926% |
| Agenus Inc. | 156.31 Million USD | -8291.571% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -65065.681% |
| Dyadic International, Inc. | 2.89 Million USD | -452403.548% |
| ImmuCell Corporation | 17.47 Million USD | -74976.972% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -41355.028% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -55992.367% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 3.69 Billion USD | -254.936% |
| IO Biotech, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -162181.331% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -5035293.474% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -131916.908% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -1635461.097% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -20774.298% |
| NextCure, Inc. | - USD | -Infinity% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -68760.308% |
| Onconetix, Inc. | 58.46 Thousand USD | -22435887.343% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -1670880.892% |
| Opthea Limited | 261.85 Thousand USD | -5009160.709% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -393809.91% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| Seer, Inc. | 15.18 Million USD | -86299.684% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -159360.248% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -3093579.245% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -11476.894% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | -7902.489% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -63097.148% |
| ChromaDex Corporation | 83.57 Million USD | -15596.063% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -108801.619% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -37946.234% |
| CRISPR Therapeutics AG | 371.2 Million USD | -3433.671% |
| Precision BioSciences, Inc. | 48.72 Million USD | -26819.778% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -20546.278% |
| Innoviva, Inc. | 310.46 Million USD | -4125.045% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -255895.316% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -53760.557% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 10 Thousand USD | -131171900.0% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -728633.333% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | -3194.09% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -475160.87% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -1562663.966% |
| Century Therapeutics, Inc. | 2.23 Million USD | -586799.329% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -62217.45% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -12859.867% |
| Autolus Therapeutics plc | 1.69 Million USD | -772408.834% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -28404.498% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -19289900.0% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | -7603.493% |
| GRI Bio, Inc. | 21.76 Million USD | -60161.864% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -516328.043% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -615730.986% |
| INmune Bio, Inc. | 155 Thousand USD | -8462609.677% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -10224.927% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -585753.181% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -1311620.0% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -152905.949% |
| Coherus BioSciences, Inc. | 257.24 Million USD | -4999.128% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -374677.143% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -830102.532% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -168761.998% |
| Histogen Inc. | 3.76 Million USD | -347928.655% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -2248957.406% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -12034028.44% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -3348730.085% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -38617.79% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -191308.142% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | -8215.288% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -8996607.819% |
| Apollomics, Inc. | 821 Thousand USD | -1597610.11% |
| Amarin Corporation plc | 306.91 Million USD | -4173.943% |
| Mesoblast Limited | 5.9 Million USD | -222150.085% |
| Turnstone Biologics Corp. | 19.3 Million USD | -67843.644% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -16590.248% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | -7373.634% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.83 Billion USD | -616.705% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -16938.201% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | -3207.488% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -985414.651% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -9275.389% |
| Insmed Incorporated | 305.2 Million USD | -4197.79% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -70098.009% |
| OmniAb, Inc. | 34.16 Million USD | -38294.802% |
| Alector, Inc. | 97.06 Million USD | -13414.249% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -10283.693% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -12735045.631% |
| Zai Lab Limited | 266.71 Million USD | -4817.985% |
| Revance Therapeutics, Inc. | 234.04 Million USD | -5504.683% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -10090053.846% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -75083.126% |
| Veracyte, Inc. | 361.05 Million USD | -3533.06% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -285197.31% |
| FibroGen, Inc. | 147.75 Million USD | -8777.849% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -8874565.945% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | -242.11% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -3123042.857% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | -3344.77% |
| TG Therapeutics, Inc. | 233.66 Million USD | -5513.75% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | -321.911% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -841825.546% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -38304.919% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -15364.931% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -22742.714% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | -2920.663% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -29208.249% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | -3857.974% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -23771556.397% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -50343.009% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -145746566.667% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -396054.428% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -10741841.824% |
| Pluri Inc. | 326 Thousand USD | -4023580.982% |
| Prothena Corporation plc | 91.37 Million USD | -14256.134% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -21660.09% |
| Celularity Inc. | 22.77 Million USD | -57504.848% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -238828.962% |
| MeiraGTx Holdings plc | 14.01 Million USD | -93480.652% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | -5158.912% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -20426.093% |
| Blueprint Medicines Corporation | 249.38 Million USD | -5159.925% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -42228.568% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -179636.914% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -36060.441% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -262472.28% |
| Cytokinetics, Incorporated | 7.53 Million USD | -174099.203% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -628927.571% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -10410.998% |
| Evogene Ltd. | 5.64 Million USD | -232474.468% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -131163.885% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -140899.678% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -273175.0% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -35810.97% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -4177352.229% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -655760.0% |
| MediciNova, Inc. | 1 Million USD | -1311620.0% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -535952.309% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -76866000.205% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | -4747.45% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | -1298.688% |
| Mereo BioPharma Group plc | 10 Million USD | -131072.0% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -229301.889% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -63197.785% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | -4753.566% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -467536.364% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | -2619.295% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -13807478.947% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -275587.264% |
| Kezar Life Sciences, Inc. | 7 Million USD | -187288.571% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -62458.184% |
| aTyr Pharma, Inc. | 353 Thousand USD | -3715820.68% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -84369.058% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -4177352.229% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -108775088.656% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | -1481.809% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -5798633.909% |
| UroGen Pharma Ltd. | 82.71 Million USD | -15758.692% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -8432.567% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -47440044.665% |
| Orgenesis Inc. | 530 Thousand USD | -2474843.396% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | -7692.18% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -5172848.224% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | -6709.178% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -5798633.909% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -76866000.205% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -872634.531% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -251923.39% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -119593.403% |
| scPharmaceuticals Inc. | 13.59 Million USD | -96399.669% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -130770.997% |
| Daré Bioscience, Inc. | 2.8 Million USD | -467055.884% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -7128813.043% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | -433.484% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -113174.611% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -21762.0% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -44369.607% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | -442.206% |
| DBV Technologies S.A. | 15.72 Million USD | -83300.305% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | -91.548% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -163742.118% |
| Molecular Templates, Inc. | 57.3 Million USD | -22789.75% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -8931.521% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -129914.868% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -190473.878% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -22227.529% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -2033019.645% |
| Adagene Inc. | 18.11 Million USD | -72324.739% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -1212210.536% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | -4439.687% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | -5146.712% |
| SciSparc Ltd. | 2.87 Million USD | -455516.534% |
| Vericel Corporation | 197.51 Million USD | -6541.082% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -222074.797% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -21906.509% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -51247.373% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -13459.932% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -12966.632% |
| ADMA Biologics, Inc. | 258.21 Million USD | -4979.953% |
| Clene Inc. | 654 Thousand USD | -2005588.073% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -51997.727% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -29327.257% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -26134.4% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -12258965.421% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -15120.701% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -17941140.836% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -22344.433% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -111459.789% |
| Trevena, Inc. | 3.12 Million USD | -419650.4% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | -1705.69% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -208506.87% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -166446.47% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -2108774.598% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -240936.384% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -18600.654% |
| Celularity Inc. | 22.77 Million USD | -57504.848% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -326767.68% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -8385837.77% |
| Cibus, Inc. | 1.81 Million USD | -721815.245% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -364266.667% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -183024.389% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -681667.152% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | -1565.365% |
| Eyenovia, Inc. | 3787.00 USD | -346374338.87% |
| Puma Biotechnology, Inc. | 235.63 Million USD | -5466.698% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -11790.246% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -2687850.82% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -16461.285% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -1449235.892% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| Geron Corporation | 237 Thousand USD | -5534583.544% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -193683.424% |
| Royalty Pharma plc | 2.35 Billion USD | -457.099% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -1787298.603% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -35491.372% |
| Humacyte, Inc. | - USD | -Infinity% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -7715900.0% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -1089368.439% |
| Notable Labs, Ltd. | 310 Thousand USD | -4231254.839% |
| Liquidia Corporation | 17.48 Million USD | -74906.862% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -1212210.536% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -72206.929% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -704368.314% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -765825.394% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | -463.575% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -18192460.539% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -275587.264% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -43723900.0% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -82694.925% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -20172.939% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -3079054.93% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | -3184.588% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -39103.802% |
| Peak Bio, Inc. | 367.87 Thousand USD | -3565548.301% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -47666.651% |
| Benitec Biopharma Inc. | 216 Thousand USD | -6072677.778% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -1480396.614% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | -969.643% |
| Immunome, Inc. | 14.01 Million USD | -93473.976% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -791523.416% |
| CervoMed Inc. | 7.14 Million USD | -183489.013% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -266889.619% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -464061.359% |
| Moolec Science SA | 905.04 Thousand USD | -1449235.892% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -1576467.589% |
| AnaptysBio, Inc. | 17.15 Million USD | -76353.926% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -533108.891% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -595324.421% |
| Lumos Pharma, Inc. | 2.05 Million USD | -639451.438% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -32109.062% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -628927.571% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -6429900.0% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -10930900.0% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -5246780.0% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | -3372.832% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | -6938.106% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -32693.0% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -1103112.784% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -84795.476% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -2301163.158% |
| HCW Biologics Inc. | 2.84 Million USD | -461481.663% |
| XOMA Corporation | 4.75 Million USD | -275587.264% |
| Nektar Therapeutics | 90.12 Million USD | -14454.937% |
| Arvinas, Inc. | 78.5 Million USD | -16609.809% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -29747.771% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -423856.044% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -2005588.073% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -749026.214% |
| Synlogic, Inc. | 3.37 Million USD | -389018.956% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -3565548.301% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -65673.454% |
| Krystal Biotech, Inc. | 50.69 Million USD | -25772.7% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -8882.353% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -240715.128% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -2917316.379% |
| MannKind Corporation | 198.96 Million USD | -6492.817% |
| Ikena Oncology, Inc. | 9.16 Million USD | -143100.873% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -11462.098% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | -4500.218% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -327929900.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -26053.325% |
| REGENXBIO Inc. | 90.24 Million USD | -14435.582% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -587978.116% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -177663.925% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -1737277.483% |
| Longeveron Inc. | 709 Thousand USD | -1849998.731% |
| Repare Therapeutics Inc. | 51.13 Million USD | -25553.101% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | -955.0% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -113174.611% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -6246185.714% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | -32.91% |
| Denali Therapeutics Inc. | 330.53 Million USD | -3868.523% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -80388.641% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -485183.019% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -16841.158% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -8605292.639% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -87822.783% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -1943188.889% |
| OmniAb, Inc. | 34.16 Million USD | -38294.802% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -61622.191% |
| Lipocine Inc. | -2.85 Million USD | 460220.569% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -585753.181% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -15797.517% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -15072.286% |
| Ocugen, Inc. | 6.03 Million USD | -217216.103% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -1134605.882% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -36251.846% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -218439.65% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -2071793.629% |
| Dominari Holdings Inc. | 2.03 Million USD | -643215.351% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | -1031.71% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -48802.807% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | -2153.729% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -104046.09% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -2749837.107% |
| Iterum Therapeutics plc | - USD | -Infinity% |